The analysis of immunohistochemical data (Fig. 7) revealed that UBE2C and AURKA expression levels are higher in undifferentiated tumors of cervical (p < 0.0001 and p < 0.004, for UBE2C and AURKA respectively) and breast (p < 0.001 and p < 0.0001, for UBE2C and AURKA respectively) cancer samples. The gene discussed is AURKA; the disease is cancer.